Laboratorios Farmaceuticos Rovi Investor Relations Material
Latest events
Q2 2025
Laboratorios Farmaceuticos Rovi
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Laboratorios Farmaceuticos Rovi S.A.
Access all reports
Laboratorios Farmacéuticos Rovi S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of proprietary and in-licensed drugs. It serves therapeutic areas including cardiovascular, hematology, and endocrinology. The company is headquartered in Madrid, Spain, and its shares are listed on the BME.
Key slides for Laboratorios Farmaceuticos Rovi S.A.
Q2 2025
Laboratorios Farmaceuticos Rovi S.A.
Q3 2024
Laboratorios Farmaceuticos Rovi S.A.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ROVI
Country
🇪🇸 Spain